qtr-two adjusted earnings per share $num-one.
qtr-three revenue $num-two million versus refinitiv ibes estimate of $4.48 billion.
qtrly scientific revenue increased num-one% year-over-year.
qtrly organic revenue declined num-one% year-over-year.
qtr-two revenue rose num-two percent to $num-three million.
qtr-three revenue $num-two million versus refinitiv ibes estimate of $1.61 billion.
sees fy capital expenditures of $num-one million to $2.0 million.
qtrly engineering technologies revenue and operating income decreased about num-one% and num-two% to $num-three million and $num - four million, respectively.
sees covid related storage demand in fiscal year-six to be at higher end of previously indicated range of $num-one million to $2.0 billion.
qtrly electronics sales increased num-one% to $1.4 billion.
qtrly total revenue increased num-one% to $num-one billion, year-over-year.
sees qtr-four year-six earnings per share $num-one.
qtr-two adjusted earnings per share $num-two.
sees covid vaccine storage demand to come in at high end of previously indicated $num-one million to $num - two million sales range for fiscal year-six.
qtrly scientific segment revenue increased num-one% to $num-two million.
sees fy year-six adjusted earnings per share about num-one%.
